Respira Therapeutics

Respira Therapeutics develops unique inhaled therapies to address significant unmet patient needs. Respira leverages industry-leading expertise and know-how to develop pulmonary products with what we believe are high probabilities of technical and clinical success. We have developed a novel, easy-to-use, and reliable dry powder inhaler (AOS™ DPI) and applied advanced particle engineering formulation technologies to create products that may offer substantial new therapeutic benefits to patients.